These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9716093)

  • 21. The impact of vaccines on pneumonia: key lessons from Haemophilus influenzae type b conjugate vaccines.
    Gessner BD; Adegbola RA
    Vaccine; 2008 Jun; 26 Suppl 2():B3-8. PubMed ID: 18793604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Haemophilus influenzae meningitis 5 years after introduction of the Haemophilus influenzae type b conjugate vaccine in Brazil.
    Ribeiro GS; Lima JB; Reis JN; Gouveia EL; Cordeiro SM; Lobo TS; Pinheiro RM; Ribeiro CT; Neves AB; Salgado K; Silva HR; Reis MG; Ko AI
    Vaccine; 2007 May; 25(22):4420-8. PubMed ID: 17449150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Haemophilus influenzae type b conjugate vaccines - a South African perspective.
    Visser A; Hoosen A
    Vaccine; 2012 Sep; 30 Suppl 3():C52-7. PubMed ID: 22939022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of haemophilus influenzae type B conjugate vaccine for prevention of meningitis in Senegal.
    Fleming JA; Dieye Y; Ba O; Mutombo wa Mutombo B; Diallo N; Faye PC; Ba M; Cisse MF; Diallo AG; Ba M; Slack MP; Weiss NS
    Pediatr Infect Dis J; 2011 May; 30(5):430-2. PubMed ID: 21099444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rethinking the benefits and costs of childhood vaccination: the example of the Haemophilus influenzae type b vaccine.
    Bärnighausen T; Bloom DE; Canning D; Friedman A; Levine OS; O'Brien J; Privor-Dumm L; Walker D
    Vaccine; 2011 Mar; 29(13):2371-80. PubMed ID: 21159324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The burden of Haemophilus influenzae type b disease in Australia and an economic appraisal of the vaccine PRP-OMP.
    Harris A; Hendrie D; Bower C; Payne J; de Klerk N; Stanley F
    Med J Aust; 1994 Apr; 160(8):483-8. PubMed ID: 8170423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haemophilus influenzae type b vaccine in Papua New Guinea: what can we expect, and how should we determine priority for child health interventions?
    Duke T
    P N G Med J; 1999; 42(1-2):1-4. PubMed ID: 11061000
    [No Abstract]   [Full Text] [Related]  

  • 28. Haemophilus influenzae type b (Hib) Vaccination WHO position paper: July 2013-Recommendations.
    WHO
    Vaccine; 2013 Dec; 31(52):6168-9. PubMed ID: 24156921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High cost is the primary barrier reported by physicians who prescribe vaccines not included in India's Universal Immunization Program.
    Kahn GD; Thacker D; Nimbalkar S; Santosham M
    J Trop Pediatr; 2014 Aug; 60(4):287-91. PubMed ID: 24567310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmes.
    Ladhani S; Heath PT; Slack MP; McIntyre PB; Diez-Domingo J; Campos J; Dagan R; Ramsay ME;
    Clin Microbiol Infect; 2010 Jul; 16(7):948-54. PubMed ID: 19889054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and immunogenicity of a conjugate vaccine against Haemophilus influenzae type b in splenectomized and nonsplenectomized patients with Cooley anemia.
    Cimaz R; Mensi C; D'Angelo E; Fantola E; Milone V; Biasio LR; Carnelli V; Zanetti AR
    J Infect Dis; 2001 Jun; 183(12):1819-21. PubMed ID: 11372038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of the introduction of a combined Haemophilus B conjugate vaccine and hepatitis B recombinant vaccine on vaccine coverage rats in a large West Coast health maintenance organization.
    Davis RL; Coplan P; Mell L; Black S; Shinefield H; Lewis E
    Pediatr Infect Dis J; 2003 Jul; 22(7):657-8. PubMed ID: 12886895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of vaccination against Haemophilus influenzae type b with and without a booster dose on meningitis in four South American countries.
    Garcia S; Lagos R; Muñoz A; Picón T; Rosa R; Alfonso A; Abriata G; Gentile A; Romanin V; Regueira M; Chiavetta L; Agudelo CI; Castañeda E; De la Hoz F; Higuera AB; Arce P; Cohen AL; Verani J; Zuber P; Gabastou JM; Pastor D; Flannery B; Andrus J
    Vaccine; 2012 Jan; 30(2):486-92. PubMed ID: 22085550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Haemophilus influenzae type b disease in HIV-infected children: a review of the disease epidemiology and effectiveness of Hib conjugate vaccines.
    Mangtani P; Mulholland K; Madhi SA; Edmond K; O'Loughlin R; Hajjeh R
    Vaccine; 2010 Feb; 28(7):1677-83. PubMed ID: 20034606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endotoxin content in Haemophilus influenzae type b vaccine.
    Ochiai M; Kataoka M; Toyoizumi H; Yamamoto A; Kamachi K; Arakawa Y; Kurata T; Horiuchi Y
    Jpn J Infect Dis; 2004 Apr; 57(2):58-9. PubMed ID: 15118211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new combination haemophilus influenzae type B and Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine for primary immunization of infants.
    Pace D; Snape M; Westcar S; Hamaluba M; Yu LM; Begg N; Wysocki J; Czajka H; Maechler G; Boutriau D; Pollard AJ
    Pediatr Infect Dis J; 2007 Nov; 26(11):1057-9. PubMed ID: 17984816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Haemophilus influenzae type b conjugate vaccine is highly effective in the Ugandan routine immunization program: a case-control study.
    Lee EH; Lewis RF; Makumbi I; Kekitiinwa A; Ediamu TD; Bazibu M; Braka F; Flannery B; Zuber PL; Feikin DR
    Trop Med Int Health; 2008 Apr; 13(4):495-502. PubMed ID: 18312475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional antibody activity elicited by fractional doses of Haemophilus influenzae type b conjugate vaccine (polyribosylribitol phosphate-tetanus toxoid conjugate).
    Romero-Steiner S; Fernandez J; Biltoft C; Wohl ME; Sanchez J; Feris J; Balter S; Levine OS; Carlone GM
    Clin Diagn Lab Immunol; 2001 Nov; 8(6):1115-9. PubMed ID: 11687449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A fully liquid diphtheria-tetanus-five component acellular pertussis-inactivated poliomyelitis--Haemophilus influenzae type b conjugate vaccine: immunogenicity and safety of primary vaccination in Taiwanese infants.
    Lin TY; Wang YH; Chang LY; Huang YC; Kao HT; Lin PY; Lu HK; Chavand P; Ortiz E
    Int J Infect Dis; 2007 Mar; 11(2):129-36. PubMed ID: 16762579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative evaluation of conjugate vaccines in the Haemophilus influenzae infection model.
    Miyazaki S; Shintani M; Matsumoto T; Tateda K; Yamaguchi K
    Can J Microbiol; 2000 Apr; 46(4):358-62. PubMed ID: 10779872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.